Starling Oncology Inc.

Last updated September 27, 2026

Organization details

Legal name
Starling Oncology Inc.
Former names
Oncology Institute, Inc. DFP Healthcare Acquisitions Corp.
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
8011 — Services-Offices & Clinics of Doctors of Medicine
Jurisdiction of incorporation
Delaware
Headquarters city
Cerritos
Headquarters state / province
California
Headquarters country
United States
Fiscal year end
December
Ticker symbol
STLN
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001799191
EIN
84-3562323

Board of directors

Chief executives

Brad Hively · Chief Executive Officer
Dates unknown

Director election results

Annual meeting of June 17, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

4 of this board's directors also sit on 3 other boards. 3 are in the same sector.

Network of Starling Oncology Inc.'s board connections Coherus Oncology Inc. Coherus Oncology Inc. AdaptHealth Corp. AdaptHealth Corp. Dianthus Therapeutics Inc. Dianthus Therapeutics... Anne McGeorge Anne McGeorge Kimberly Jo Tzoumakas Kimberly Jo Tzoumaka... Mark Stolper Mark Stolper Richard A. Barasch Richard A. Barasch Starling Oncology Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$2,862,309
17 purchases by 1 insider
Sold, last 12 months
$14,183,952
12 sales by 6 insiders
Date Insider Transaction Shares Price Value
Nov 9, 2026 Chernett Jorey 10% owner Open-market purchase +48,294 $3.65 $176,273
Nov 6, 2026 Chernett Jorey 10% owner Open-market sale −2,851,061 $3.99 $11,375,733
Aug 21, 2026 Brad Hively Director Open-market sale −298,853 $6.51 $1,945,533
Aug 14, 2026 Chernett Jorey 10% owner Open-market purchase +12,000 $6.54 $78,480
Jul 27, 2026 Brad Hively Director Grant or award +27,108 — —
Jul 27, 2026 Karen Marie Johnson Director Grant or award +31,124 — —
Jul 27, 2026 Mohit Kaushal Director Grant or award +33,133 — —
Jul 27, 2026 Anne McGeorge Director Grant or award +41,165 — —
Jul 27, 2026 Kimberly Jo Tzoumakas Director Grant or award +29,116 — —
Jul 27, 2026 Mark Stolper Director Grant or award +31,124 — —
Jul 27, 2026 Mark L. Pacala Director Grant or award +30,120 — —
Jul 21, 2026 Chernett Jorey 10% owner Open-market purchase +18,000 $5.27 $94,860
Jul 14, 2026 Podnos Yale Officer (Chief Medical Officer) Option exercise +17,974 $1.87 $33,611
Jul 14, 2026 Podnos Yale Officer (Chief Medical Officer) Open-market sale −17,974 $6.43 $115,573
Jul 14, 2026 Podnos Yale Officer (Chief Medical Officer) Option exercise +5,478 $2.00 $10,956

Organizations in the same sector, closest in location and size first.

Questions about Starling Oncology Inc.

Who is the CEO of Starling Oncology Inc.?

Brad Hively is Starling Oncology Inc.'s Chief Executive Officer.

How many directors are on Starling Oncology Inc.'s board?

Starling Oncology Inc.'s board has 11 directors: Anne McGeorge, Brad Hively, Gabriel Ling, Karen Marie Johnson, Kimberly Jo Tzoumakas, Maeve O'Meara, Mark L. Pacala, Mark Stolper, Mohit Kaushal, Ravi Yang Sarin and 1 other.

Are Starling Oncology Inc. insiders buying or selling shares?

Over the last 12 months, Starling Oncology Inc. insiders bought $2.9 million of shares in 17 purchases and sold $14.2 million of shares in 12 sales on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="starling-oncology-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.